Unexpected pain syndrome during a phase I study of lv methyl-CCNU.
D006801:Humans; D007263:Infusions, Parenteral; D009369:Neoplasms / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000009:adverse effects*; D010146:Pain / Q000139:chemically induced*; D012673:Semustine / Q000009:adverse effects* / Q000627:therapeutic use; D013577:Syndrome
D009607:Nitrosourea Compounds; D012673:Semustine